Christopher J.H. Davitt

551 total citations
12 papers, 373 citations indexed

About

Christopher J.H. Davitt is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Christopher J.H. Davitt has authored 12 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Microbiology. Recurrent topics in Christopher J.H. Davitt's work include Viral gastroenteritis research and epidemiology (5 papers), Escherichia coli research studies (3 papers) and Bacterial Infections and Vaccines (3 papers). Christopher J.H. Davitt is often cited by papers focused on Viral gastroenteritis research and epidemiology (5 papers), Escherichia coli research studies (3 papers) and Bacterial Infections and Vaccines (3 papers). Christopher J.H. Davitt collaborates with scholars based in United States, Ireland and Sweden. Christopher J.H. Davitt's co-authors include Ed C. Lavelle, Lisa A. Morici, James B. McLachlan, Sarah M. Baker, Chad J. Roy, Jonathan Kurtz, John T. Prior, Jan Holmgren, Ivan S. Coulter and Craig P. McEntee and has published in prestigious journals such as The Journal of Immunology, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Christopher J.H. Davitt

12 papers receiving 367 citations

Peers

Countries citing papers authored by Christopher J.H. Davitt

Since Specialization

Citations

This map shows the geographic impact of Christopher J.H. Davitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J.H. Davitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J.H. Davitt more than expected).

Fields of papers citing papers by Christopher J.H. Davitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J.H. Davitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J.H. Davitt. The network helps show where Christopher J.H. Davitt may publish in the future.

Co-authorship network of co-authors of Christopher J.H. Davitt

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J.H. Davitt. A scholar is included among the top collaborators of Christopher J.H. Davitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J.H. Davitt. Christopher J.H. Davitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection 2023 ·npj Vaccines ·Christina Kackos, Jennifer DeBeauchamp, Christopher J.H. Davitt, (unknown), Robert E. Sealy, Julia L. Hurwitz, Marcelo M. Samsa, Richard J. Webby	22
2	mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19 2023 ·Microbiology Spectrum ·Christina Kackos, Sherri L. Surman, Bart G. Jones, Robert E. Sealy, Trushar Jeevan, Christopher J.H. Davitt, Sergei Pustylnikov, Tamarand L. Darling, Adrianus C. M. Boon, Julia L. Hurwitz, Marcelo M. Samsa, Richard J. Webby	7
3	Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses 2021 ·Pharmaceutics ·John T. Prior, Christopher J.H. Davitt, Jonathan Kurtz, (unknown), James B. McLachlan, Lisa A. Morici	48
4	Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine 2021 ·npj Vaccines ·Sarah M. Baker, Erik W. Settles, Christopher J.H. Davitt, (unknown), (unknown), Joseph P. Hoffmann, Yihui Wang, Jacob P. Bitoun, (unknown), Jason W. Sahl, Paul Keim, Chad J. Roy, James B. McLachlan, Lisa A. Morici	33
5	An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses 2019 ·npj Vaccines ·Stéphanie Longet, Áine Abautret-Daly, Christopher J.H. Davitt, Craig P. McEntee, (unknown), Mónica Rosa, Ivan S. Coulter, Jan Holmgren, Sukanya Raghavan, Ed C. Lavelle	34
6	Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines 2019 ·Mucosal Immunology ·Christopher J.H. Davitt, Stéphanie Longet, Aqel Albutti, (unknown), (unknown), (unknown), Craig P. McEntee, Mónica Rosa, Ivan S. Coulter, Michael Lebens, Joshua Tobias, Jan Holmgren, Ed C. Lavelle	19
7	A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates 2017 ·Vaccines ·Sarah M. Baker, Christopher J.H. Davitt, (unknown), (unknown), Kasi Russell‐Lodrigue, Chad J. Roy, Lisa A. Morici	39
8	A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens 2016 ·Journal of Controlled Release ·Christopher J.H. Davitt, Edel A. McNeela, Stéphanie Longet, Joshua Tobias, (unknown), Craig P. McEntee, Mónica Rosa, Ivan S. Coulter, Jan Holmgren, Ed C. Lavelle	26
9	Naturally-derived bacterial nano-particles engage diverse innate receptors, driving the activation of dendritic cells and leading to the establishment of potent adaptive immune responses. 2016 ·The Journal of Immunology ·Christopher J.H. Davitt, (unknown), (unknown), Ed C. Lavelle, Lisa A. Morici	5
10	Gram-Negative Bacterial Outer Membrane Vesicles Inhibit Growth of Multidrug-Resistant Organisms and Induce Wound-Healing Cytokines 2016 ·Open Forum Infectious Diseases ·Sarah M. Baker, Christopher J.H. Davitt, Lisa A. Morici	3
11	Delivery strategies to enhance oral vaccination against enteric infections 2015 ·Advanced Drug Delivery Reviews ·Christopher J.H. Davitt, Ed C. Lavelle	129
12	Harnessing the antibacterial and immunological properties of mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections 2014 ·Biochemical Pharmacology ·Áine Abautret-Daly, Christopher J.H. Davitt, Ed C. Lavelle	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact